The KCTD12 Knockout A-549 Polyclonal Cells product provides a human lung adenocarcinoma-derived polyclonal cell population in which KCTD12 has been disrupted via CRISPR/Cas9-mediated gene editing. This loss-of-function model enables functional interrogation of KCTD12 within a cancer-relevant epithelial background. The polyclonal format preserves heterogeneous knockout genotypes while eliminating wild-type KCTD12 expression, offering a robust tool for studying the gene??s role in signaling pathways and cellular phenotypes. The cells are supplied as a ready-to-use population, facilitating streamlined integration into diverse experimental workflows.
The host A-549 cell line was established from the lung adenocarcinoma of a 58-year-old Caucasian male and exhibits adherent epithelial morphology. Widely utilized as a model of human alveolar type II epithelium, A-549 cells are a cornerstone in non-small cell lung cancer (NSCLC) research and drug development. Their relevance extends to studies of tumorigenesis, metastasis, and therapeutic resistance, making them an ideal chassis for investigating genetic perturbations relevant to adenocarcinoma biology.
KCTD12 functions as a substrate-specific adaptor for the CUL3-RBX1 E3 ubiquitin ligase complex. It directly binds Dishevelled proteins (DVL1, DVL2), promoting their ubiquitination and proteasomal degradation, thereby attenuating Wnt/??-catenin signal transduction. This activity is regulated by canonical Wnt ligands such as WNT3A and by CUL3 neddylation. Separately, KCTD12 associates with GABAB receptor subunits GABBR1 and GABBR2 to modulate receptor kinetics and downstream GABAergic synapses. Through self-association into homodimers, KCTD12 integrates signals from both pathways, influencing downstream effectors including ??-catenin stability and GABAB receptor activity. Representative pathway components encompass Frizzled receptors, Dishevelled, GSK3??, ??-catenin, CUL3-RBX1 ligase, and NEDD8.
In the A-549 lung adenocarcinoma context, KCTD12 knockout models its potential tumor-suppressive functions linked to Wnt pathway regulation. Loss of KCTD12-dependent Dishevelled degradation may stabilize ??-catenin, driving oncogenic transcription and cellular proliferation. Conversely, disrupted GABAB receptor modulation could impact non-canonical signaling networks. This model thus supports investigations into the dual roles of KCTD12 in cancer cell homeostasis and neurotransmitter signaling, with implications for both NSCLC and neuropsychiatric disorders such as major depressive disorder and schizophrenia.
Researchers can employ these polyclonal knockout cells in diverse applications, including dissection of Wnt pathway regulation in lung cancer, investigation of GABAB receptor modulation, and validation of ubiquitin ligase adaptors as drug targets. Representative assays include Western blot analysis of DVL and ??-catenin levels, co-immunoprecipitation of the CUL3-KCTD12 interaction, ubiquitination assays, flow cytometric measurement of Wnt activity, cell proliferation and migration/invasion assays, and TOPFlash luciferase reporter assays. These cells provide a versatile platform for both mechanistic studies and therapeutic screening. For additional information or custom requests, please contact Ascent Research.
